Amir Zarebkohan | Nanomedicine | Best Researcher Award

Published on by Cell Biologist

Dr. Amir Zarebkohan | Nanomedicine | Best Researcher Award

Tabriz University of Medical Sciences | Iran

Dr. Amir Zarebkohan’s research focuses on the development of advanced nanomedicine strategies for targeted drug delivery and cancer therapy. His work integrates medical nanotechnology and physiology to design innovative nanosystems capable of precise drug transport within biological environments. He specializes in smart targeted delivery platforms, nano–bio interface studies, and nano chemo-immunotherapy approaches aimed at improving therapeutic efficacy while minimizing systemic toxicity. His current projects involve the co-delivery of cyclophosphamide and HLH peptide using D8 and RIVAP-modified chitosan nanoparticles, engineered to respond to the redox conditions of the tumor microenvironment for glioma targeting in rat models. Additionally, he is developing chitosan-based nanoparticles containing dendrimers loaded with cyclophosphamide and sitagliptin, further functionalized with targeting ligands for enhanced delivery efficiency. His research emphasizes translational applications of nanotechnology in oncology and the exploration of biocompatible polymeric carriers for controlled and localized drug release. Through his studies, Dr. Zarebkohan contributes to advancing nano-chemoimmunotherapeutic platforms that bridge the gap between nanoscience and clinical medicine, offering potential breakthroughs in the treatment of complex and resistant cancers.

Profiles:  Google Scholar | Scopus | Orcid

Featured Publications:

Zarebkohan, A., & colleagues. (2024). Enhanced docetaxel therapeutic effect using dual targeted SRL-2 and TA1 aptamer conjugated micelles in inhibition Balb/c mice breast cancer model. Scientific Reports, 14, Article 75042.

Zarebkohan, A., & colleagues. (2024). Discovery of a novel dual targeting peptide for human glioma: From in-silico simulation to acting as targeting ligand. Advanced Pharmaceutical Bulletin, 14, Article 033.

Zarebkohan, A., & colleagues. (2023). Dual targeting salinomycin-loaded smart nano-micelles for enhanced accumulation and therapeutic outcome in breast cancer. International Journal of Pharmaceutics, 123095.

Zarebkohan, A., & colleagues. (2023). CDX-modified chitosan nanoparticles remarkably reduce therapeutic dose of fingolimod in the EAE model of mice. International Journal of Pharmaceutics, 122815.

Zarebkohan, A., & colleagues. (2023). Exosomal transmission of viruses, a two-edged biological sword. Cell Communication and Signalling, 21, Article 37.

Mohammad Shahangir Biswas | Cellular Toxicity | Best Researcher Award

Published on by Cell Biologist

Dr. Mohammad Shahangir Biswas | Cellular Toxicity | Best Researcher Award

Dr. Mohammad Shahangir Biswas | University of Science & Technology Chittagong | Bangladesh

Dr. Mohammad Shahangir Biswas is a distinguished academician and researcher in the fields of Biochemistry, Biotechnology, and Public Health, currently serving as an Assistant Professor at the University of Science and Technology Chittagong (USTC), Bangladesh. He worked as a Postdoctoral Research Associate at the University of Wisconsin-Madison, USA. His academic and research journey reflects a dedication to global health issues, molecular biology, and neurophysiology. Previously, he served as Assistant Professor at Khwaja Yunus Ali University. He has co-authored more than 48 scientific publications, including multiple first-author articles in The Lancet and other Q1 journals. With international exposure and extensive research collaborations, he brings a strong commitment to scientific excellence. Dr. Biswas is fluent in English, speaks Japanese (basic), and is a native speaker of Bangla. He is passionate about public health advancement, biomedical research, and mentoring the next generation of scientists.

Publication Profiles:

Scopus
Orcid

Education:

Dr. Biswas earned his Ph.D. in Biochemistry/Medical Science from Tokyo Medical and Dental University, supported by the prestigious MEXT Scholarship. He later completed a Postdoctoral Fellowship at the University of Wisconsin-Madison, USA, contributing to advanced research in public health and neurophysiology. Prior to his doctoral studies, he obtained his M.Sc. (Thesis) and B.Sc. (Hons.) degrees in Biochemistry and Molecular Biology from the University of Rajshahi, Bangladesh. His early academic excellence earned him multiple scholarships and positioned him for a strong career in scientific research. This strong educational foundation, combined with global exposure, has equipped him with expertise in molecular biology, public health research, and biotechnological innovation. Dr. Biswas continues to use his academic training to lead impactful research, particularly in disease burden analysis and biomedical therapeutics.

Experience:

Dr. Mohammad Shahangir Biswas brings a diverse academic and research background spanning over a decade. He served as Assistant Professor at Khwaja Yunus Ali University and later joined USTC as Assistant Professor, soon to be active as an Associate Professor. He conducted impactful postdoctoral research at the University of Wisconsin-Madison, contributing to global public health research initiatives. His teaching and research cover Biochemistry, Biotechnology, Neurophysiology, and Public Health. In addition to his teaching roles, Dr. Biswas is a Senior Collaborator in the Global Burden of Disease (GBD) Study, contributing to several high-impact international publications. His strong leadership, grant acquisition, and mentoring skills have made him an influential figure in Bangladesh’s biomedical research landscape. He remains dedicated to fostering collaborative research and academic excellence both locally and internationally.

Awards and Honors:

Dr. Biswas has received numerous awards and recognitions throughout his academic journey. Notably, he was awarded the Japanese MEXT Scholarship for his Ph.D. studies in Japan—a highly competitive and prestigious international award. His undergraduate and postgraduate achievements at the University of Rajshahi were recognized with merit-based scholarships. Additionally, he received an R&D Grant from the Ministry of Science and Technology, Bangladesh, for conducting impactful research. His research contributions to major international collaborations such as the Global Burden of Disease Study have further established his credibility and excellence in global health research. His work has been accepted in top-tier journals including The Lancet and JACC, cementing his role as a leading researcher from Bangladesh on the global stage. These honors reflect his dedication, academic brilliance, and contributions to advancing medical science, especially in the fields of public health, neurodegeneration, and biochemistry.

Research Focus:

Dr. Shahangir Biswas’s research focuses on the molecular basis of disease, global health burden, neurodegeneration, and biomedical intervention strategies. He has contributed significantly to the Global Burden of Disease (GBD) Study, publishing extensively on cancer, cardiovascular diseases, and immunization trends. His work integrates biochemistry, biotechnology, and public health, aiming to identify mechanistic pathways of diseases like Alzheimer’s and tuberculosis, and develop therapeutic interventions. Additionally, he explores snake venom biochemistry, vaccine development, and the impact of social factors such as social media on mental health. Dr. Biswas is passionate about interdisciplinary research combining molecular diagnostics, bioinformatics, and global epidemiological data. His current work includes identifying biomarkers, assessing toxicology impacts, and predicting future disease trends using large-scale datasets. With over 48 peer-reviewed publications, he maintains a strong collaboration network internationally and is a vocal advocate for translational research that informs policy and clinical practice.

Publications Top Notes: 

  1. The global, regional, and national burden of cancer, 1990–2023 – The Lancet

  2. The global burden of cancer: Forecasts to 2050 – The Lancet, Accepted

  3. Global trends in childhood vaccination coverage 1980–2023 – The Lancet, Accepted

  4. Burden of Cardiovascular Diseases in 204 countries (1990–2023) – JACC, Accepted

  5. Biochemical Profile of Bangladeshi Russell’s Viper Venom – Journal of Toxicology, Accepted

  6. Neurodegeneration in Alzheimer’s Disease: Mechanisms and Therapies – Advanced Neurology, Accepted

  7. Musculoskeletal Extrapulmonary TB in Lagos, Nigeria – Health Sci Rep, Accepted

  8. Cytokines and Vascular Inflammation in Viral Infections – Health Sci Rep, Accepted 2

  9. Social Media and Mental Health of Young Adults in Bangladesh – Health Sci Rep, Accepted

  10.  Emerging Evidence on HKU5-CoV-2 – Romanian Journal of Infectious Diseases

Conclusion:

In conclusion, Dr. Mohammad Shahangir Biswas is a highly suitable candidate for the Best Researcher Award, given his consistent and impactful contributions to biomedical and public health research, his impressive publication record in world-renowned journals, and his strong academic foundation. He has demonstrated a deep commitment to advancing scientific knowledge with global relevance and interdisciplinary reach. With continued strategic focus on leadership roles in research, mentorship, and innovation, Dr. Biswas is well-positioned not only to receive this award but also to make even greater contributions to science and society in the years ahead.

Charles Wang | Epigenomics | Distinguished Scientist Award

Published on by Cell Biologist

Prof. Charles Wang | Epigenomics | Distinguished Scientist Award

Prof. Charles Wang | Loma Linda University Center for Genomics | United States

Dr. Changhong Wang (now known as Dr. C. Wang), a U.S. citizen, is a distinguished molecular toxicologist and genomic scientist currently serving as Director and Tenured Professor at the Center for Genomics, Loma Linda University. Originally from China, Dr. Wang holds dual graduate degrees in Public Health and Toxicology from Tongji Medical University and the University of Washington, respectively. His early career laid the foundation for pivotal research into environmental toxicants and gene-environment interactions. Dr. Wang has significantly contributed to the understanding of xenobiotic metabolism, DNA methylation, and the transgenerational effects of toxins and epigenetics. His leadership in molecular genetics research is reflected in numerous peer-reviewed publications and competitive grants. A passionate educator and mentor, Dr. Wang’s work bridges foundational science and clinical application, marking him as a strong contender for the Research for Distinguished Scientist Award.

Publication Profile: 

Socpus

Education:

Dr. Wang received his Ph.D. in Toxicology from the University of Washington, Seattle. His doctoral work focused on aflatoxin metabolism and liver glutathione S-transferases in nonhuman primates, mentored by Dr. David L. Eaton. Prior to that, he earned an MPH in Environmental Epidemiology from Tongji Medical University, China, where he developed a foundation in public health and environmental sciences. His dual training in toxicology and epidemiology provided a unique cross-disciplinary approach to health sciences. This strong academic background enables Dr. Wang to address critical questions regarding how environmental exposures affect human health, especially through epigenetic and genomic pathways. His educational path reflects a continuous pursuit of scientific excellence and translational impact, positioning him to bridge molecular discoveries with public health relevance—a crucial quality for a candidate of the Distinguished Scientist Award.

Experience:

Dr. Wang currently serves as Director and Tenured Professor at the Center for Genomics, School of Medicine, Loma Linda University (LLU), where he has led translational and mechanistic genomic research. His responsibilities span academic leadership, mentorship, and collaborative research within the Division of Molecular Genetics. Prior to this, he held the role of Associate Professor-Adjunct in Microbiology & Molecular Genetics at LLU. His earlier roles include postdoctoral and research scientist positions at institutions where he investigated environmental carcinogens, drug metabolism, and gene expression. Over three decades, Dr. Wang has built a multidisciplinary portfolio in toxicology, environmental health, and genomics. He is a leading voice in DNA methylation, epigenetic inheritance, and cancer biology. His integrative research style and administrative skills have allowed him to create impactful programs that foster innovation and interdisciplinary collaboration—an essential trait for any distinguished scientist.

Awards and Honors:

Dr. Wang’s academic journey has been decorated with prestigious accolades from the outset. He received the Excellent Medical Student Award  and Distinguished Graduate Student Award from Tongji Medical University. His pioneering research at the University of Washington earned him the First-Place Graduate Award for Research Excellence from the Society of Toxicology in New Orleans. He was awarded multiple Student Travel Awards from the University of Washington’s School of Public Health. These early recognitions underscore his long-standing commitment to scientific excellence and innovation. Dr. Wang’s later career has been marked by continuous success in publication, grant acquisition, and institutional leadership. These honors reflect both peer recognition and academic merit, reinforcing his status as a credible and outstanding candidate for the Research for Distinguished Scientist Award.

Research Focus:

Dr. Wang’s research focuses on environmental toxicology, genomics, and epigenetics, particularly in the context of transgenerational health effects. He investigates how toxicants such as cadmium, aflatoxin B1, and p,p’-DDE affect gene regulation through epigenetic reprogramming. His lab has pioneered work on DNA methylation, histone modifications, and miRNA signatures in diseases like cancer, neurodevelopmental disorders, and diabetes. Recent work has addressed the effects of e-cigarette exposure on neonatal brain methylomes and the epigenetic inheritance of addiction vulnerability. Dr. Wang also explores copy number variation and drug resistance mechanisms in oncology, using cutting-edge tools like single-cell RNA sequencing and patient-derived models. His integrative, multi-omics approach allows for deep mechanistic insights and clinical translation. His ability to lead multidisciplinary teams in high-impact research areas demonstrates both visionary thinking and the technical prowess necessary for distinguished scientific leadership.

Publications Top Notes:

  1. Cadmium-induced negative calcium balance in multiparous birth women

  2. Effect of cadmium on bone calcium in nonpregnant mice: Direct evidence on bone

  3. Cadmium’s impact on bone calcium in mouse dams: Itai-Itai-like syndrome model

  4. Induction of drug-metabolizing enzymes by BHA, ethoxyquin, and oltipraz

  5. Diquat and ciprofibrate effects on hepatic enzyme expression

  6. Mu-class GSTs mediate aflatoxin B1 epoxide conjugation in Macaca liver

  7. CYP1B1 expression analyzed in human tissues via hybridization techniques

  8. Cloning and characterization of alpha-class GSTs from Macaca liver

  9. Proteomic comparison of hepatocyte preparation methods

  10.  CYP3A41B polymorphism linked to puberty onset and breast cancer risk*

Conclusion:

In conclusion, Dr. Wang’s long-standing academic excellence, innovative research in toxicogenomics, and his leadership in advancing our understanding of environmental and epigenetic factors in disease clearly distinguish him as an outstanding scientist. His achievements fulfill and surpass the expectations for the Research for Distinguished Scientist Award. His profile reflects not only a deep commitment to rigorous science but also a visionary approach to public health and molecular research. With minor expansion in global engagement and translational outreach, Dr. Wang’s impact could be even more far-reaching. He is highly recommended for this honor.

Long Yu | Biosensor | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Long Yu | Biosensor | Best Researcher Award

Assoc. Prof. Dr. Long Yu | Wuhan University | China

Dr. Long Yu is a highly accomplished Han Chinese researcher, currently serving as a Postdoctoral Fellow in Clinical Medicine at Wuhan University. With a deep passion for pharmaceutical analysis, he has pioneered innovative approaches using lanthanide-based metal-organic frameworks (Ln-MOFs). His academic journey has been marked by excellence, including direct admission to a Ph.D. program and multiple national-level scholarships. Dr. Yu has published over 20 high-impact SCI papers, many in top-tier journals such as Advanced Materials, ACS Nano, and Analytical Chemistry. Recognized for his independent research capabilities, he has secured major national funding, including the NSFC Youth Project and China Postdoctoral Science Foundation grant. His work is shaping the future of biosensing and molecular diagnostics, especially in nucleic acid detection. Dr. Yu’s remarkable academic achievements, innovative research direction, and collaborative impact make him an outstanding candidate for the Best Researcher Award.

Publication Profile: 

Orcid

Education:

Dr. Long Yu’s educational background reflects a consistent trajectory of academic excellence. He completed his Bachelor of Science in Pharmacy at Shihezi University, where he graduated and was directly admitted to a Ph.D. program without an entrance exam. He pursued a Direct-Ph.D. in Pharmacy at Wuhan University, under the mentorship of Prof. Yuxiu Xiao. His doctoral research focused on the rational design and application of programmable lanthanide-based metal-organic frameworks (Ln-MOFs) in pharmaceutical analysis. Currently, he is a Postdoctoral Fellow in Clinical Medicine at Wuhan University, guided by Professors Gaosong Wu and Xiang Zhou. Through his academic journey, Dr. Yu has demonstrated strong interdisciplinary capabilities, combining pharmaceutical sciences, materials chemistry, and biosensing technology to advance the field of molecular diagnostics.

Experience:

Dr. Long Yu has cultivated deep expertise in biosensors and pharmaceutical analysis throughout his academic and research journey. He is currently a Postdoctoral Fellow in Clinical Medicine at Wuhan University, working on translational biosensing technologies with Professors Gaosong Wu and Xiang Zhou. He earned his Ph.D. in Pharmacy at Wuhan University under the supervision of Prof. Yuxiu Xiao, where he led several high-impact research projects on programmable metal-organic frameworks (MOFs). His undergraduate foundation was built at Shihezi University , where he graduated among the top of his class. Dr. Yu has served as the principal investigator for five competitive research grants, including prestigious national funding. His academic footprint includes 21 SCI-indexed publications and significant contributions to both theoretical research and practical biosensor development. He excels at multidisciplinary collaboration, combining chemistry, materials science, and clinical application—demonstrating both leadership and innovation in his research.

Awards and Honors:

Dr. Long Yu has received multiple accolades that highlight his academic and research excellence. During his Ph.D., he was awarded the National Scholarship for Graduate Students twice, a prestigious recognition of outstanding academic performance and research capabilities in China. He also received the 1st Prize for Oral Presentation at the National Academic Symposium for Pharmacy Postgraduates in , and the Excellent Poster Award at the 9th National Conference on Drug Analysis in the same year. In addition to academic awards, he has secured several competitive grants as the Principal Investigator, including the National Natural Science Foundation of China Youth Project, the China Postdoctoral Science Foundation General Program, and the Hubei Province Postdoctoral Innovation Talent Program. These achievements demonstrate both national-level recognition and institutional confidence in his independent research potential, marking him as one of the leading young scientists in his field.

Research Focus:

Dr. Long Yu’s research is centered on the rational design of programmable lanthanide-based metal-organic frameworks (Ln-MOFs) for pharmaceutical analysis and biosensing applications. His work bridges materials science and biomedical engineering, enabling high-performance detection platforms for nucleic acids, neurotransmitters, kinases, and epigenetic modifications. He has developed Ln-MOF-integrated systems with excellent selectivity, sensitivity, and biocompatibility for real-time monitoring and clinical diagnostics. A notable feature of his research is the integration of MOF materials with cutting-edge technologies such as CRISPR-Cas, nanozymes, and multivariate sensing platforms. His innovative designs contribute to amplification-free gene mutation detection, ultra-efficient nucleic acid extraction, and responsive ctDNA biosensors. Dr. Yu’s interdisciplinary approach not only expands the utility of MOFs in biomedicine but also paves the way for smart and customizable sensing systems. With 21 high-quality SCI publications and ongoing funded projects, his work is both academically significant and practically relevant in clinical diagnostics and precision medicine.

Publications Top Notes: 

  1.  Lanthanide MOF-Integrated CRISPR-Cas Technology for Amplification-Free Gene Mutation Assay

  2.  Customized Pyrophosphate Nanosensor Based on Lanthanide MOFs for Nucleic Acids Detection

  3.  Polarity Sensor Using Multivariate Lanthanide MOF for Biosensing Platforms

  4.  Levodopa Cascade Polymerization with MOF Nanozyme for Butyrylcholinesterase Dual-Mode Assay

  5.  Enhancing Kinase Detection via Programmable Lanthanide MOF with ATP-to-ADP Conversion

  6. Ultra-Efficient Nucleic Acids Extraction Using Programmable Lanthanide MOF

  7. Bioreaction-Compatible Bivariate Lanthanide MOF Sensor for ctDNA Detection

  8. Adaptable Cobalt MOF for DNA Epigenetic Modification Detection

  9. Trinity Strategy Using Perovskite Nanozyme for Biomarker Reporting

  10.  Nanoporous Crystalline Materials for Nucleic Acids Recognition

Conclusion:

In conclusion, Dr. Long Yu is highly suitable for the Best Researcher Award based on his exceptional research productivity, innovation in the design and application of Ln-MOFs, and substantial contributions to high-impact journals. His early career achievements, particularly as a postdoctoral fellow, show a promising trajectory that is well-aligned with the criteria of research excellence, originality, and potential societal impact. With continued international exposure, broader interdisciplinary collaboration, and efforts to translate research into clinical or industrial outcomes, Dr. Yu is not only deserving of the current award but is also poised to become a leading figure in his field in the years to come.

Yuxin Peng | Cell Adhesion Mechanisms | Best Researcher Award

Published on by Cell Biologist

Prof. Yuxin Peng | Cell Adhesion Mechanisms | Best Researcher Award

Prof. Yuxin Peng | Zhejiang University | China

Dr. Yuxin Peng is a distinguished researcher and educator in the field of biomedical and exercise science engineering. Currently serving as a ZJU 100 Young Professor at Zhejiang University, China, he has made significant strides in developing flexible sensors, smart wearable systems, and human–machine interaction technologies. With a Ph.D. and postdoctoral training at the National University of Singapore, his research integrates cutting-edge materials science, biomechanics, and AI-driven health monitoring systems. His work has been consistently published in high-impact journals like Science Advances, Advanced Science, IEEE Transactions, and Soft Robotics, reflecting both depth and innovation. Dr. Peng’s contributions are not only academic but also practical, with several of his innovations applied in rehabilitation, sports science, and robotics. His dedication and cross-disciplinary expertise make him a strong candidate for recognition such as the Best Researcher Award.

Publication Profiles: 

Orcid
Scopus

Education:

Dr. Yuxin Peng received his doctoral degree (Ph.D.) in an engineering-related discipline, laying a strong foundation in biomedical engineering, biomechanics, and sensor technologies. His early academic pursuits were rooted in multidisciplinary innovation, merging engineering principles with human physiology and robotics. To further deepen his scientific understanding, he pursued postdoctoral research at the prestigious National University of Singapore, focusing on biomedical systems and smart rehabilitation. During his academic training, Dr. Peng built expertise in wearable sensors, motion tracking systems, and soft robotics—technologies that play a crucial role in personalized healthcare and intelligent rehabilitation. His education trajectory demonstrates both depth and diversity, preparing him to address complex biomedical challenges with integrated, high-tech solutions. It also laid the groundwork for his future leadership roles and impactful research career at Zhejiang University, where he now mentors young researchers and leads innovation in health engineering.

Experience:

Dr. Yuxin Peng has built an impressive academic and research career spanning over a decade. He has been a ZJU 100 Young Professor at Zhejiang University, affiliated with the Institute of Exercise Science and Health Engineering. In this role, he leads interdisciplinary research projects in wearable technology, flexible sensors, and human motion analysis. Prior to this, he served as a Research Fellow at the Department of Biomedical Engineering, National University of Singapore, where he focused on intelligent health systems and rehabilitation technologies. His hands-on experience in global, high-tech research environments has allowed him to develop collaborations with experts in robotics, materials science, and medical engineering. He has supervised numerous projects and students, while continuously publishing in high-impact journals. His experience demonstrates a rare blend of academic rigor and real-world application, making him a leader in human-centered biomedical innovation and smart rehabilitation systems.

Research Focus:

Dr. Yuxin Peng’s research focuses on wearable systems, smart sensors, soft robotics, and biomedical signal processing for human motion monitoring and rehabilitation. His work addresses real-world problems such as gait analysis, joint motion detection, force sensing, and rehabilitation assistance. By integrating AI, flexible electronics, and biocompatible materials, he develops high-performance sensors and intelligent exosuits for applications in sports science, elderly care, and physical therapy. Notable innovations include graphene-based aerogels, hydrogel biosensors, and multi-feature neural networks for gesture recognition. His lab has also contributed to optical waveguide sensors, virtual reality rehabilitation, and MI-controlled exoskeletons. The overarching goal of his work is to enable non-invasive, real-time, and personalized health monitoring through smart technology. By pushing the boundaries of soft, adaptive, and human-interactive systems, Dr. Peng’s research is at the forefront of the next generation of intelligent biomedical engineering solutions.

Publications Top Notes:

  1. Hydroplastic Foaming of Graphene Aerogels and AI Tactile Sensors – Science Advances

  2. Underwater Instant Adhesive Hydrogel Interfaces for Robust Biosensing – Advanced Science

  3. Flexible Segmented Assemblable Fiber Optic Sensor for Multi-Joint Monitoring – Soft Robotics (Accepted)

  4. Calibration-Free Optical Waveguide Bending Sensor for Soft Robots – Soft Science

  5. Distributed Plantar 3D Force Measurement System – Sensors and Actuators A

  6. Superelastic Graphene Nanofibrous Aerogels for Intelligent Sign Language – Small

  7. Omnidirectional Soft Bending Sensor for Joint Monitoring – IEEE TIE

  8. Shank-RIO: Ranging-Inertial Odometry for Gait and Positioning – IEEE TIM

  9. Exosuit with Bidirectional Hand Support via Gesture Recognition – IEEE TNSRE

  10.  Advances in Flexible Bending Sensors and Applications – IJ Smart & Nano Materials

Conclusion:

In conclusion, Dr. Yuxin Peng exhibits all the qualities of a top-tier, award-worthy researcher. His work is characterized by scientific rigor, high-impact publication, and a vision for solving real-world healthcare challenges using cutting-edge sensor and robotics technologies. As a respected academic at Zhejiang University with a solid international research background, Dr. Peng has already contributed significantly to wearable health tech and rehabilitation sciences. His ability to combine soft material innovation, artificial intelligence, and biomechanics into novel human-machine interaction systems places him at the forefront of biomedical engineering research. While there is room for growth in the areas of commercialization and global academic engagement, his career trajectory, research excellence, and societal relevance of his innovations make him a highly deserving candidate for the Best Researcher Award.

Shahab Uddin | Microbiology | Best Researcher Award

Published on by Cell Biologist

Mr. Shahab Uddin | Microbiology | Best Researcher Award

Mr. Shahab Uddin | Department of Life Sciences, Lanzhou University | China

Shahab Uddin, is a dedicated and accomplished microbiologist with a strong background in microbial ecology, molecular biology, and nanotechnology. He is currently pursuing a Ph.D. in Microbiology at Lanzhou University, China, where he is engaged in cutting-edge research involving antibiotic-conjugated magnetic nanoparticles for periodontitis diagnosis. With numerous international publications in high-impact journals and experience across microbiology, mechanobiology, and neuroinflammation research, Shahab is recognized for his exceptional technical skills and scientific contributions. His career has spanned various research institutions, including Sungkyunkwan University in South Korea, where he conducted pivotal studies on nanoparticles and microbial pathogens. Driven by scientific curiosity and a collaborative spirit, Shahab continues to contribute to advancements in microbial and biomedical research. Fluent in English, Urdu, and proficient in scientific communication, he is an ideal candidate for the Best Researcher Award, representing both innovation and perseverance in the life sciences.

Publication Profiles: 

Google Scholar
Orcid

Education:

Shahab Uddin began his academic journey in Pakistan, completing his M.Phil. in Microbiology from Quaid-I-Azam University, Islamabad. During his postgraduate studies, he specialized in microbial ecology and environmental microbiology. His thesis work laid the foundation for his deeper interest in microbial mechanisms and genetic interactions. He further advanced his academic credentials by enrolling in the Ph.D. Microbiology program at Lanzhou University, China. His doctoral research focuses on the application of nanotechnology in microbial diagnostics, specifically using magnetic nanoparticles for periodontal disease detection. Over the years, he has enhanced his technical skills in qPCR, molecular cloning, bioaerosol sampling, and nanoparticle synthesis. His education has been enriched by international collaborations and interdisciplinary exposure, especially in mechanobiology and neuroinflammation. Shahab’s education reflects a blend of foundational microbiology and cutting-edge biomedical research, enabling him to tackle complex scientific challenges with innovation and precision.

Experience:

Shahab Uddin has worked as a Research Assistant at Lanzhou University, actively contributing to a nanotechnology-driven project aimed at improving periodontitis diagnostics through magnetic nanoparticle conjugation. His work bridges microbiology, nanotechnology, and diagnostics, showcasing his interdisciplinary expertise. He has also conducted research under Prof. Sungsu Park at the 4DBM Laboratory, Sungkyunkwan University, South Korea, where he was responsible for nucleic acid extraction, synthesis of biocompatible nanoparticles, and detection of airborne pathogens. These roles reflect his strong command over laboratory techniques such as qPCR, microbial culturing, and nanoparticle formulation. His involvement in multiple international collaborations and multi-disciplinary projects highlights his ability to adapt and contribute meaningfully to diverse research environments. His excellent work ethic, dedication to scientific rigor, and impressive publication record position him as a highly experienced and innovative researcher, making him a suitable candidate for recognition such as the Best Researcher Award.

Awards and Honors:

Shahab Uddin has received notable academic recognitions throughout his career. During his early education, he was awarded a fellowship by Islamia Model College, Timergara, which covered his tuition and admission fees. He received a laptop through the Prime Minister’s Laptop Scheme at the University of Peshawar, acknowledging his academic merit and performance. His consistent involvement in internationally recognized research projects and publications in top-tier journals has brought him visibility and respect within the scientific community. His work on microbial calcium carbonate precipitation, nanoparticle toxicity, and Parkinson’s disease treatments has earned accolades in both ecological and biomedical research circles. Beyond formal awards, his participation in collaborative research in China and South Korea is a testament to his growing international reputation. These honors reflect his commitment to scientific advancement and his ability to represent his country and field at a global level.

Research Focus:

Shahab Uddin’s research focuses on the interface of microbiology, nanotechnology, and biomedical science. His doctoral work involves using antibiotic-conjugated magnetic nanoparticles for rapid and precise preconcentration of periodontal bacteria, a novel approach for periodontitis diagnosis. He has also investigated the neuroinflammatory effects of fusion proteins, the role of nicotine in neuroprotection in Parkinson’s disease, and microbial-induced calcium carbonate precipitation for environmental applications. Shahab’s interests include mechanobiology, microbial genetics, and pathogen detection using qPCR. He is particularly passionate about translating microbial research into diagnostic and therapeutic applications. His collaborations with institutions in South Korea and China reflect a global perspective and adaptability in interdisciplinary research. With a portfolio that includes molecular biology, environmental microbiology, and advanced nanomaterials, Shahab’s work stands at the forefront of modern microbiological science. His research bridges basic science and applied solutions, aiming to contribute to global health, sustainable environments, and innovative diagnostics.

Publications Top Notes: 

  1. A comparative study on HSA and α-MSH fusion proteins for anti-neuroinflammatory effects – Neuropeptides

  2. Rigid linker peptides enhance stability and anti-inflammatory efficacy of HSA-α-MSH fusions – Biotechnology Journal

  3. Autophagy and UPS pathway in nicotine-induced protection for Parkinson’s disease – Experimental Brain Research

  4. Nicotine-mediated therapy in transgenic C. elegans model for Parkinson’s – Frontiers in Aging Neuroscience

  5. Microbially induced calcium carbonate precipitation to improve soil mechanics – Ecological Engineering

  6. Psychrotolerant Serratia marcescens HI6 characterization from glacier – Applied Ecology & Environmental Research

  7. Retrospective study on tuberculosis incidence in Dir Lower, Pakistan – Hospital Pharmacy

  8. Mechanobiological analysis of nanoparticle toxicity – Nanomaterials

  9. Microfabricated devices to study tensile stress on cells and tissues – BioChip Journal

  10. Incidence of HBV, HCV, HIV among blood donors in Peshawar – Population

Conclusion:

In conclusion, Shahab Uddin is an outstanding and promising researcher with a broad and impactful academic portfolio. His contributions span critical scientific areas including microbial pathogenesis, nanotechnology-enabled diagnostics, and neurodegenerative disease models. His dedication, innovation, and consistency in research make him highly deserving of recognition through the Best Researcher Award. While there is scope for leadership expansion and broader outreach, his current achievements—especially his multi-disciplinary publications and international collaborations—are commendable and reflect a researcher who is not only productive but also forward-thinking. Granting him this award would not only honor his contributions but also inspire continued scientific excellence and innovation in microbiology and beyond.

Shuxin Han | Molecular Mechanisms Signaling | Best Researcher Award

Published on by Cell Biologist

Dr. Shuxin Han | Molecular Mechanisms Signaling | Best Researcher Award

Dr. Shuxin Han | Xinjiang University | China

Dr. Shuxin Han is a distinguished molecular biologist and professor at Xinjiang University, widely recognized for his pioneering work in hepatobiliary and metabolic biology. With a research career spanning over two decades, Dr. Han has made major contributions to understanding how Kruppel-like factors, especially KLF15, regulate endobiotic and xenobiotic metabolism, impacting drug detoxification and metabolic disease mechanisms. He earned his Ph.D. from Kent State University and has held prestigious positions at Harvard Medical School and Case Western Reserve University. His groundbreaking studies have been published in high-impact journals like Nature Metabolism and Nature Communications, with several articles naming him as first or corresponding author. In addition to research, Dr. Han serves as a reviewer for top-tier journals in pharmacology, hepatology, and clinical science. He is also an academic leader, currently shaping the next generation of scientific talent and metabolic disease research in China.

Publication Profile: 

Scopus

Education:

Dr. Shuxin Han began his academic journey in Animal Sciences, earning a bachelor’s degree from Anhui Agricultural University (1994–1998). He advanced to a research assistant role at Peking University (1999–2000), where he deepened his scientific foundation. He then moved to the U.S. to pursue a Master’s in Biology at Temple University (2000–2003), followed by a Ph.D. in Molecular Biology from Kent State University (2004–2009), focusing on metabolic biology and gene regulation. This progression from general animal sciences to highly specialized molecular biology reflects a systematic and deep commitment to biomedical research. His strong academic preparation laid the foundation for a research career investigating how transcriptional regulators impact health and disease. Dr. Han’s training spans world-class institutions across both China and the United States, equipping him with diverse scientific perspectives and techniques.

Experience:

Dr. Shuxin Han has accumulated rich research and academic experience over nearly 30 years. His early career included a pivotal research assistant role at Peking University, followed by advanced training in biology and molecular biology at Temple and Kent State Universities. He completed prestigious postdoctoral training at Harvard Medical School (2009–2012) and Case Western Reserve University (2012–2015), where he later became a Senior Research Associate (2015–2019). He returned to China in 2019 as a Researcher at the University of Science and Technology of China First Affiliated Hospital, simultaneously engaging in academic duties at the university until 2023. Currently, he serves as a Professor and Academic Leader at Xinjiang University. Throughout his career, Dr. Han has built strong international collaborations, led research groups, and guided innovative projects in metabolic biology, demonstrating his leadership, research excellence, and academic mentorship capabilities.

Research Focus:

Dr. Shuxin Han’s research centers on the molecular regulation of metabolism, particularly focusing on the hepatobiliary and gastrointestinal systems. His work has elucidated the critical role of the Kruppel-like factor (KLF) family, especially KLF15, in controlling endobiotic and xenobiotic metabolism (EXM). These pathways govern how the body metabolizes both internal compounds and external substances like drugs. Dr. Han’s studies have shown that KLF15 acts as a master regulator, influencing drug resistance, liver injury, and metabolic homeostasis. His discoveries offer new insight into personalized medicine and treatment for metabolic disorders and drug-related toxicities. With numerous first-author and corresponding-author publications in journals such as Nature Metabolism, Nature Communications, and Drug Metabolism and Disposition, his work has significantly impacted both fundamental science and clinical applications. He is also active in peer-reviewing for top-tier journals and is recognized for his leadership in translational research.

Publications Top Notes:

  1. Unveiling KLF15 as the Key Regulator of Cyclosporine A Metabolism and Adverse Effects – Drug Metabolism and Disposition, 2025

  2. Distribution and Functional Significance of KLF15 in Mouse Cerebellum – Molecular Brain, 2025

  3. Personalized Statin Therapy: Targeting Metabolic Processes – Heliyon, 2025

  4. Current Status and New Directions for Hepatocellular Carcinoma Diagnosis – Liver Research, 2024

  5. KLF15-Cyp3a11 Axis Regulates Rifampicin-Induced Liver Injury – Drug Metabolism and Disposition, 2024

  6. Advancing Drug Delivery and Bioengineering in Liver Research – Bioengineering and Translational Medicine, 2024

  7. Advances in IL-7 Research on Tumor Therapy – Pharmaceuticals, 2024 (Co-author)

  8. Pathogenic Mechanisms in Alcoholic Liver Disease – Journal of Translational Medicine, 2023

  9. Beta-Hydroxybutyrate Effects on iPSC-Derived Cardiac Myocytes – Biomolecules, 2022

  10. Interactions Between Intestinal Flora and Bile Acids – International Journal of Molecular Sciences, 2022 (Corresponding author)

Conclusion:

In conclusion, Dr. Shuxin Han is a highly deserving candidate for the Best Researcher Award. His pioneering work on KLF15 and metabolic regulation has reshaped fundamental understanding in the field of hepatobiliary biology and pharmacology. His academic background, research productivity, international experience, and editorial service all reflect a well-rounded and impactful scientist. While there is room to increase clinical translation and international engagement, the depth, originality, and consistency of his research make him a strong contender for this recognition. Honoring Dr. Han with this award would acknowledge a career dedicated to scientific advancement with substantial implications for human health and drug therapy.

Alejandro Rojas | Immunology Cellular Interactions | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Alejandro Rojas | Immunology Cellular Interactions | Best Researcher Award

Assist. Prof. Dr. Alejandro Rojas | Austral University of Chile | Germany

Dr. Alejandro Alfredo Rojas Fernández is a distinguished Chilean molecular biotechnologist and neuroscientist, currently serving as CEO of Berking Theranostics UG in Hamburg, Germany, and Assistant Professor at the Universidad Austral de Chile. With over two decades of research spanning neurodegeneration, immunology, and viral pathogenesis, Dr. Rojas-Fernández has emerged as a leading expert in molecular diagnostics and theranostics. His innovative work has significantly impacted global health, notably through his contributions to SARS-CoV-2 research and senolytic therapies. A dual academic and entrepreneur, he bridges fundamental science and clinical application, actively publishing in top-tier journals such as Nature Aging, Molecular Psychiatry, and Journal of Cell Biology. Fluent in interdisciplinary collaboration, his efforts have been internationally recognized with multiple honors. With a passion for translational science, Dr. Rojas-Fernández continues to inspire the next generation of biomedical innovators through mentorship and leadership in biotechnology and neuroscience.

Publication Profile:

Orcid

Education:

Dr. Alejandro Rojas-Fernández earned his PhD in Biology from the University of Konstanz, Germany (2006–2010), where his research focused on the regulation of Hdm2/HdmX-mediated ubiquitination and neddylation—mechanisms central to protein stability and cancer biology. Prior to his doctorate, he completed his engineering degree in Molecular Biotechnology (2004–2005) and his B.Sc. in Molecular Biotechnology Engineering (2000–2004) at the Faculty of Sciences, University of Chile—one of Latin America’s leading research institutions. His multidisciplinary education integrates molecular biology, neurobiology, immunology, and translational medicine, equipping him with the foundational and advanced tools to tackle complex biomedical challenges. Dr. Rojas-Fernández’s academic training has been marked by academic excellence and international mobility, enabling him to collaborate and lead research projects across Europe and Latin America.

Experience:

Dr. Rojas-Fernández brings over 20 years of experience in translational biomedical research, academia, and biotech innovation. As CEO of Berking Theranostics UG, he spearheads the development of personalized diagnostic platforms and therapeutics, with a focus on neurodegenerative and inflammatory diseases. In his role as Assistant Professor at Universidad Austral de Chile (20% appointment), he leads the Medical Biotechnology Laboratory within the Centre for Interdisciplinary Studies on the Nervous System (CISNe), contributing to scientific training and cutting-edge research. He previously trained and collaborated at institutions such as the University of Dundee, University of Queensland, and University of Constance, advancing molecular mechanisms of SUMOylation, proteostasis, inflammasome biology, and viral-host interactions. His interdisciplinary expertise allows him to translate complex cellular insights into tangible clinical applications, and his leadership has resulted in high-impact publications, product pipelines, and strategic biotech partnerships in Europe and Latin America.

Awards and Honors:

Dr. Rojas-Fernández has received multiple prestigious honors recognizing his innovative biomedical research. In February 2025, he was named “Innovator of the Month” by Hamburg Invest for groundbreaking biotech contributions in Germany. He was awarded the Medal of the City of Valdivia for his vital role in controlling the SARS-CoV-2 pandemic, one of the highest local honors in Chile. Additionally, he received the 2nd of October Medal for Science and Innovation, recognizing his scientific leadership in Chile’s Los Ríos region. These accolades underscore his impact on global public health, neurodegenerative research, and biotechnology entrepreneurship. His consistent recognition reflects a career dedicated to translational excellence, fostering international collaboration, and advancing science for the benefit of society. His scientific achievements continue to inspire innovation and interdisciplinary approaches within the global scientific community.

Research Focus:

Dr. Alejandro Rojas-Fernández’s research centers on cellular stress responses, ubiquitin/SUMO signaling, neurodegeneration, and host-pathogen interactions. A core focus is the molecular crosstalk between autophagy, protein quality control, and inflammasome activation in brain and immune cells. He has made significant advances in understanding the effects of SARS-CoV-2 on microglia, mechanisms of senescence in aging brains, and nanobody-based viral neutralization. His studies also explore the intersection of endoplasmic reticulum stress and neurodegenerative pathways, using high-content screening and proteomics to uncover therapeutic targets. He actively translates molecular insights into diagnostics and theranostic tools, positioning him at the forefront of personalized medicine. As CEO of a biotech startup, he is developing platforms that integrate biomarker discovery with AI for neuroinflammation profiling. His research bridges fundamental biology and clinical applications, promoting innovative therapies for Alzheimer’s, Parkinson’s, cancer, and viral infections.

Publications Top Notes: 

  1. Negative Modulation of Macroautophagy by Stabilized HERPUD1… – Front Cell Dev Biol, 2022

  2. SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia… – Mol Psychiatry, 2022

  3. The p97/VCP segregase is essential for arsenic-induced degradation of PML… – J Cell Biol, 2023

  4. Lack of Parkinsonian Pathology after Proteasome Inhibitor Injection… – Front Aging Neurosci, 2021

  5. NSPA modulates postsynaptic NMDAR stability… – BMC Biol, 2020

  6. Role of PSMD14 in Golgi-to-ER transport and APP processing – Cells, 2020

  7. WDR90 in NLRC4 inflammasome and Salmonella resistance – Dev Comp Immunol, 2019

  8. Proteomic identification of APC interaction partners – Mol Cancer Res, 2019

  9. DHX15 regulates CMTR1-dependent gene expression – Life Sci Alliance, 2018

  10.  Membrane ruffling by polarized stim1 and orai1 – Sci Reports, 2017

Conclusion:

Dr. Alejandro Alfredo Rojas Fernández stands out as a pioneering researcher who consistently delivers scientifically rigorous, socially impactful, and clinically relevant work. His career spans critical sectors—basic research, applied biotechnology, and public health—making him a model example of the translational scientist. With accolades from both European and Latin American institutions and a track record of high-impact publications, Dr. Rojas exemplifies what it means to be a globally relevant and community-driven scientist. His work during the COVID-19 pandemic, innovations in molecular neuroscience, and leadership in therapeutic biotechnology underscore his immense value to the global research community. In conclusion, he is not only a suitable but a highly deserving candidate for the Best Researcher Award.

Shima Shafiee | Cell Structure Analysis | Best Researcher Award

Published on by Cell Biologist

Dr. Shima Shafiee | Cell Structure Analysis | Best Researcher Award

Dr. Shima Shafiee, Razi University, Iran

Shima Shafiee is an accomplished Iranian researcher specializing in computer systems architecture and bioinformatics, with a strong focus on machine learning applications in biological data analysis. She recently earned her Ph.D. in Computer Engineering from Razi University, where she focused on predictive modeling of protein-peptide binding interactions. Currently under consideration at the IDEL Lab, Shahid Bahonar University of Kerman, Shima has authored numerous national and international publications. With a rich background in algorithm optimization and artificial intelligence, her research stands at the intersection of computational biology, deep learning, and evolutionary algorithms. Shafiee’s work has contributed to the development of predictive tools in bioinformatics, such as DP-site and SPPPred, and she consistently ranks at the top of her academic cohort. Her ability to integrate traditional computer engineering concepts with advanced biological research makes her a notable candidate for the Best Researcher Award.

Publication Profile: 

Google Scholar

Strengths for the Award:

  1. Strong Academic Foundation
    Dr. Shafiee has a stellar academic record, graduating first in her Ph.D. class at Razi University with a CGPA of 3.77 and a thesis grade of 3.98, under the supervision of respected experts in computer engineering and bioinformatics.

  2. Innovative Interdisciplinary Research
    Her research bridges computer systems architecture, machine learning, and bioinformatics, with notable contributions to protein-peptide binding prediction, a critical domain in drug discovery and computational biology.

  3. High-Impact Publications
    She has published in IEEE/ACM Transactions, Applied Soft Computing, and Methods, reflecting both quality and visibility in international forums. Tools like SPPPred and DP-site demonstrate her practical impact in bioinformatics.

  4. Research Originality and Versatility
    Dr. Shafiee has developed hybrid models combining genetic programming, support vector machines, and deep learning, with practical tools and open-source contributions.

  5. Early Recognition and Outreach
    She has been active in academic dissemination since 2015, with selected papers in national and international conferences, showing early promise and consistency.

  6. Teaching and Mentorship
    Through her roles as a lecturer at multiple institutions, she has contributed to academic growth at the grassroots level.

Areas for Improvement:

  1. International Collaboration & Visibility
    While her publication quality is strong, Dr. Shafiee could expand her global visibility through collaborations with international research labs, EU Horizon, or NIH-funded projects.

  2. Post-Ph.D. Grant Applications
    She could benefit from applying for independent research grants or postdoctoral fellowships to lead projects that could shape the future of AI in biology.

  3. Open-Source Software and Data Availability
    While her models are impactful, increased accessibility via open-source repositories (e.g., GitHub) would boost reproducibility and encourage broader adoption.

  4. Industry Impact Metrics
    More emphasis on industry collaborations, patents, or application of models in clinical/biotech settings would enhance translational impact.

Education:

Shima Shafiee completed her Ph.D. in Computer Engineering (2016–2024) from Razi University, specializing in Computer Systems Architecture. Her dissertation titled “Application of learning-based models in predicting of protein-peptide binding interactions” earned her a thesis grade of 3.98/4.00 and an overall CGPA of 3.77. She worked under the guidance of Dr. Abdolhossein Fathi and Dr. Ghazaleh Taherzadeh, focusing on bioinformatics using deep learning, ensemble learning, and evolutionary algorithms. Prior to her Ph.D., she was ranked third in her Master’s program (2015). Shafiee’s educational background is rooted in computational problem-solving, algorithm development, and cross-disciplinary research involving biological data. Her consistent academic excellence and high-ranking performance culminated in her being recognized as the top Ph.D. student in 2025, a testament to her dedication and scholarly capabilities. Her education blends rigorous theory with innovative applied research, making her exceptionally well-prepared for high-impact contributions in academia and industry.

Experience:

Shima Shafiee’s experience spans both academic and applied computer engineering roles. She began her journey with an internship at Kimia Pardaz Pars Company (2013). Between 2015 and 2016, she served as a lecturer for computer fundamentals at Fajr High School and Al-Zahra Seminary School in Jiroft, where she taught introductory computer science to pre-university students. These experiences highlight her foundational teaching skills and outreach to educational institutions in her community. Her major academic contribution began during her Ph.D., where she collaborated with IDEL Lab and contributed to developing tools like SPPPred and DP-site, combining genetic programming, support vector machines, and deep learning to predict protein-peptide binding regions. Her experience uniquely blends educational outreach, algorithmic development, and publication-driven research in machine learning, optimization, and computational biology, reflecting her versatility and impact across the scientific and academic spectrum.

Awards & Honors:

Shima Shafiee has earned multiple distinctions recognizing her academic and research excellence. In 2015, she was named the third-place student in her Master’s program, demonstrating early academic excellence. Her continuous dedication to research and scholarship led her to be recognized as the first-place student in her Ph.D. program in 2025. One of her papers was selected at the 2nd International Congress of Electrical Engineering, Computer Science, and Information Technology (2015), highlighting the innovation and relevance of her early research in optimization algorithms. Her high publication output, including appearances in top-tier venues like IEEE/ACM Transactions on Computational Biology and Bioinformatics and Applied Soft Computing, reflects a consistent standard of excellence. These honors collectively showcase her as a standout figure in her field, with both academic and applied contributions acknowledged at national and international levels.

Research Focus:

Shima Shafiee’s research lies at the intersection of machine learning, bioinformatics, and computational systems engineering. Her primary focus is the prediction of protein-peptide binding interactions using intelligent algorithms such as genetic programming, ensemble models, and deep learning techniques. She has proposed several innovative hybrid models combining sequence-based and structure-based features to identify critical interaction residues. Her doctoral thesis and publications have led to the development of tools like SPPPred and DP-site, which aid in biological sequence analysis, with applications in drug discovery, protein function prediction, and biomedical engineering. Shafiee also has a strong background in optimization algorithms, especially particle swarm optimization (PSO), applied to computationally intensive problems like bin packing. Her ability to blend theoretical computing with practical biological data analysis makes her contributions valuable to both computational scientists and biologists, and positions her as a leading candidate for research recognition awards in AI and bioinformatics.

Publications Top Notes: 

  • 🧠 SPPPred: sequence-based protein-peptide binding residue prediction using genetic programming and ensemble learning (IEEE/ACM TCBBS, 2022)

  • 🔍 Prediction of protein–peptide-binding amino acid residues regions using machine learning algorithms (CSICC, 2021)

  • 🧬 Combination of genetic programming and SVM-based prediction of protein-peptide binding sites (Journal of Computing and Security, 2021)

  • 🧪 Prediction of protein–peptide binding residues using classification algorithms (IEEE Bioengineering Conf, 2020)

  • 🧠 A Review of the Uses of AI in Protein Research (Peptide Science Conf, 2019)

  • 🤖 DP-site: dual deep learning method for protein-peptide interaction site prediction (Methods, 2024)

  • 🧬 Protein-peptide interaction region prediction using generative sampling & ensemble DL (Applied Soft Computing, 2025)

  • 🧠 Comparing classification vs. segmentation predictors in protein-peptide interaction (CSICC, 2025)

  • 🧬 Leveraging structure-based and learning-based predictors in protein-peptide interaction (ICCKE, 2024)

  • 📘 Application of learning-based models in protein-peptide binding (Ph.D. Dissertation, 2024)

Conclusion:

Dr. Shima Shafiee is a highly suitable candidate for the Best Researcher Award based on her academic excellence, interdisciplinary research achievements, and consistent contributions to the fields of artificial intelligence and bioinformatics. Her ability to bridge computer science and biological challenges has resulted in meaningful and applicable solutions. She has displayed originality, depth, and foresight in her work, developing novel methods that align with modern computational biology trends.

Sukanta Nath | Cancer Research | Distinguished Scientist Award

Published on by Cell Biologist

Dr. Sukanta Nath | Cancer Research | Distinguished Scientist Award

Dr. Sukanta Nath, Atal Bihari Vajpayee Regional Cancer Centre, India

Dr. Sukanta Nath is a dedicated Research Scientist with over 13 years of experience in molecular biology, virology, and cancer research. He currently serves at the Atal Bihari Vajpayee Regional Cancer Centre, Agartala, Tripura, where he has led several impactful studies in oral cancer patient care. Holding a Ph.D. in Biotechnology from Gauhati University, Dr. Nath has consistently demonstrated excellence in scientific inquiry, especially in clinical intervention studies. His collaborative works with clinical and academic experts have produced over 10 peer-reviewed publications in reputed journals. Dr. Nath’s research emphasizes evidence-based nursing practices, molecular diagnostics, and the improvement of post-surgical outcomes in cancer patients. Known for his commitment to translational research, Dr. Nath is playing a pivotal role in bridging molecular science with patient-centered care in North-East India. His multidimensional expertise and scholarly contributions make him a deserving candidate for recognition as a Distinguished Scientist.

Publication Profile: 

Scopus

Strengths for the Award:

  1. Extensive Research Experience:
    With over 13 years of hands-on experience in molecular biology, cancer research, and virology, Dr. Nath has a well-established research career that aligns with the award’s standards.

  2. Focused Contributions to Cancer Research:
    His work at Atal Bihari Vajpayee Regional Cancer Centre has significantly contributed to oral cancer patient management, particularly through randomized intervention studies improving postoperative recovery and mental health.

  3. High Research Output:
    He has authored or co-authored 10+ peer-reviewed publications, many of which focus on novel and under-explored aspects such as nursing intervention in cancer care—a progressive and human-centered approach.

  4. Multidisciplinary Approach:
    Dr. Nath bridges molecular diagnostics, clinical research, and public health, evident in his work on HPV molecular epidemiology and AML treatment reviews.

  5. Collaborative and Institutional Impact:
    His collaborations with clinicians, nurses, and academic institutions highlight his team-oriented and translational research vision, helping integrate academic outputs into real-world healthcare.

Areas for Improvement:

  1. International Exposure:
    Dr. Nath could enhance his academic profile with international fellowships, collaborative projects, or presentations at global conferences, which would add broader recognition and perspective to his impactful regional work.

  2. Grant Acquisition & Leadership Roles:
    Documented principal investigator roles or research funding/grant awards would strengthen his leadership credentials in scientific research.

  3. Recognition & Awards:
    While he has a commendable publication record, more national or state-level recognitions, fellowships, or memberships in professional bodies (like ICMR, DBT, etc.) would boost his candidacy for national-level honors.

Education:

Dr. Sukanta Nath’s academic foundation is rooted in the biological sciences, beginning with a B.Sc. in Botany, Zoology, and Physiology from Calcutta University (2003, First Class). He went on to complete his M.Sc. in Biotechnology from Utkal University in 2006, securing First Class (67%). His research potential culminated in a Ph.D. in Biotechnology from Gauhati University, awarded in 2018, where he specialized in molecular biology and translational biomedical science. His education reflects a progressive mastery of theoretical and applied biotechnology, allowing him to engage in complex interdisciplinary research. Despite modest early academic challenges in higher secondary and matriculation, Dr. Nath’s academic trajectory sharply ascended, reflecting perseverance and intellectual growth. His doctoral training equipped him with specialized skills in molecular diagnostics, research design, and bioanalytical tools, which now form the backbone of his professional research work in cancer and infectious disease.

Professional Experience:

Dr. Nath is presently serving as a Research Scientist at the Atal Bihari Vajpayee Regional Cancer Centre, Tripura, since April 2020, where he conducts pivotal research on postoperative outcomes and interventions in oral cancer patients. Previously, he worked as a Research Associate at the College of Fisheries, Central Agricultural University, Tripura (2018–2019), contributing to institutional-level biotech projects. In 2017–2018, he served as a Molecular Scientist and Quality Manager at Agility Diagnostics Pvt. Ltd., Delhi, a NABL-accredited molecular diagnostics lab, where he gained valuable experience in molecular testing and lab quality control. With over 13 years of interdisciplinary experience, Dr. Nath has successfully combined clinical and molecular biology expertise, making impactful contributions to oncology, diagnostics, and public health. His adaptability across academic, clinical, and industry environments illustrates his wide-ranging capabilities as a biomedical researcher and project leader.

Awards and Honors:

While specific named awards are not listed in the provided resume, Dr. Sukanta Nath’s contributions have earned peer recognition through frequent lead and co-author roles in high-impact publications. His ongoing collaboration with clinicians, epidemiologists, and nursing researchers has positioned him as a sought-after expert in cancer-related intervention studies in North-East India. He has been an instrumental figure in pioneering randomized clinical studies assessing fatigue, anxiety, and quality of life in post-surgical oral cancer patients—work that has been accepted in internationally indexed journals. His contributions to the molecular epidemiology of HPV in Indian women also reflect national relevance. The volume and scope of his work, alongside a sustained publication record, underline a distinguished career in translational cancer research. Nomination for the Distinguished Scientist Award is a well-aligned recognition of his achievements and continued potential to contribute at the national level.

Research Focus:

Dr. Nath’s primary research interest lies in molecular biology, oncology, and virology, with a strong emphasis on translational studies that impact patient care. He has led intervention-based research evaluating the role of nursing and clinical protocols in improving postoperative recovery among oral cancer patients. His work assesses anxiety, fatigue, and quality of life post-surgery using evidence-based methodologies. Dr. Nath has also contributed significantly to molecular epidemiology, particularly studying the distribution of high-risk HPV genotypes among women in North-East India. His experience in diagnostics and biotech allows him to approach clinical problems from both biomedical and molecular perspectives, making his research integrative and impactful. The focus on nursing intervention studies, rarely explored in Indian cancer centers, demonstrates his commitment to holistic cancer care. His future goals involve scaling such studies to wider patient populations and contributing to national cancer care protocols.

Publications Top Notes:

  1. 📘 Effectiveness of a supportive educational intervention on pain and physical function among patients undergone abdominal surgery: A randomized controlled trial

  2. 📗 Effectiveness of comprehensive nursing intervention on alleviating postoperative fatigue and anxiety in patients with oral cancer

  3. 📕 Molecular epidemiology and genotype distribution of genital high-risk human papillomavirus among women in North–East India

  4. 📙 Effectiveness of Nursing Interventions on Anxiety among Postoperative Oral Cancer Patients in Regional Cancer Centre, Tripura

  5. 📒 Importance of Nursing Intervention in Alleviating Post-Surgical Fatigue for Patients with Oral Cancer

  6. 📓 Does comprehensive nursing intervention improve post-surgical anxiety in patients with oral cancer?

  7. 📔 Post-Surgical Evaluation of Quality of Life in Patients with Oral Cancer: An Intervention Study from India

  8. 📚 Assessment of Fatigue and Quality of Life amongst Post-Operative Oral Cancer Patients: A Randomized Case Control Study

  9. 📙 Effect of Comprehensive Nursing Intervention on Anxiety and Quality of Life in Postoperative Patients with Oral Cancer

  10. 📗 Prognosis and Treatment in Acute Myeloid Leukemia: A Comprehensive Review

Conclusion:

Dr. Sukanta Nath has demonstrated dedicated service, innovative research, and strong scientific output in the fields of molecular biology and oncology, particularly with a patient-centric approach to oral cancer care. His work addresses a critical healthcare challenge in North-East India and proposes practical solutions backed by rigorous research methodologies.